loader image
Friday, November 28, 2025
71.2 F
McAllen
- Advertisement -

Texas Gov. Greg Abbott tests negative for COVID-19 four days after positive test

Translate to Spanish or other 102 languages!

Gov. Greg Abbott said he tested negative for COVID-19 on Saturday, four days after a positive diagnosis. Photo Credit:  Sophie Park/The Texas Tribune
Gov. Greg Abbott said he tested negative for COVID-19 on Saturday, four days after a positive diagnosis. Photo Credit:  Sophie Park/The Texas Tribune
 

The Texas Tribune

- Advertisement -

BY KATE MCGEE / THE TEAXS TRIBUNE

Texas Gov. Greg Abbott says he has now tested negative for COVID-19, four days after testing positive for the virus.

“I am told that my infection was brief and mild because of the vaccination I received,” Abbott said in a video he posted on Twitter Saturday afternoon. “So, I encourage others who have not yet received the vaccination to consider getting one.”

- Advertisement -

Abbott said he will continue to quarantine as recommended by doctors and that the first lady, Cecilia Abbott, continues to test negative.

Abbott contracted the virus as the pandemic surges across Texas, with new cases and hospitalizations increasing to levels not seen since the wave in the winter, and the state nearing its previous pandemic peak.

The governor received Regeneron’s monoclonal antibody treatment after testing positive. He said in the video statement he would continue working to open additional antibody therapy centers across the state. Texas recently opened nine antibody infusion centers statewide in an effort to reserve hospital capacity for the most serious cases and prevent hospitalizations. 

Regeneron antibodies are recommended to treat “mild to moderate COVID-19” for people 12 years and older who have tested positive and “are at high risk for progressing to severe COVID-19.”

- Advertisement -

When Abbott announced he tested positive, he said he was not experiencing any symptoms. He did not say whether he experienced any symptoms throughout the past four days.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

AMA Adopts New Public Health Policies to Improve Health of the Nation

The American Medical Association (AMA) gathered physician and medical student leaders from all corners of medicine at its Interim Meeting of the House of Delegates to shape guiding policies on emerging health care topics.

Study Finds Best Strategy for Reducing Belly Fat

Over the last few years, research has shown that having excessive visceral fat — the fat surrounding the abdominal area that protects internal organs — can be detrimental to a person’s health.

FDA Approves Gene Therapy for Treatment of Spinal Muscular Atrophy

The U.S. Food and Drug Administration approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in adult and pediatric patients 2 years of age and older with confirmed mutation in the survival motor neuron 1 (SMN1) gene. Itvisma is an adeno-associated virus (AAV) vector-based gene therapy.

Educating Older Adults On Age-Related Weight Gain, Dec. 5th

The “Living with Weight Gain” program is part of STHS & Prominence Health’s “Senior Living Seminar Series,” which focuses on providing essential education on common health issues affecting the elderly population
- Advertisement -
×